Recently, Cui et al. [61] proved that NF-κB activation enhances the expression of survivin in bladder cancer cell lines and in vivo, leading thereby to enhanced proliferation and apoptosis inhibition. This evidence concerns the gene BIRC5 and urinary bladder cancer.